Twist Bioscience collaborates with Berry Gene, will jointly develop a new portfolio of NGS products


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Twist Bioscience collaborates with Berry Gene, will jointly develop a new portfolio of NGS products
This collaboration can provide a variety of NGS detection solutions

Twist Bioscience, a provider of high quality synthetic DNA through a silicon platform company, today announced a partnership with China's leading Berry Gene, a supplier of high-throughput sequencing (NGS) in China, has reached a strategic cooperation and will add Twist's NGS targeted enrichment and library preparation tools to its products, aiming to promote the high-standard development of precision medical in vitro diagnostics in China.

This product combines Berry Gene's expertise in genomics and high-throughput sequencing (NGS), as well as Twist Bioscience's large-scale manufacturing capabilities, and can provide a variety of NGS detection solutions. The combined product aims to provide researchers with high-quality tools for better application in the screening of tumours and genetic diseases.

"We are very happy to cooperate with Berry Gene, which is one of the most popular and leading companies in the gene sequencing industry in China," said Dr Emily M. Leproust, CEO and co-founder of Twist Bioscience. "Berry has extensive experience in transforming genetic testing technology into clinical applications and has achieved remarkable results. In recent years, Berry Gene has been at the forefront of using NGS to detect diseases and is committed to making more Chinese people enjoy To the health benefits of gene sequencing technology. Twist is honoured to add our NGS solution to Berry Gene’s products."

The NGS products provided by Twist are unique in that they have unparalleled uniformity and have all been quality-verified (QC). The new product will provide Berry Gene with the highest-quality NGS product portfolio today, which will further promote the high-standard development of precision medical in vitro diagnostics in China.

Berry Gene and Twist Bioscience will work closely to develop a more innovative and cutting-edge NGS product portfolio to maintain a leading position in the diagnosis and screening of genetic diseases, and provide Berry Gene with more, better and timely Research and IVD solutions.

Every oligonucleotide of Twist has been verified by NGS to ensure the accuracy of each probe sequence and the presence of all probes in the delivered probe pool, which will further improve the accuracy of our products. We are very I am glad to add Twist NGS series products to our product line. "Dr Zhou Daixing, general manager of Berry Gene said.

Tags : #TwistBioscience #LatestNewsonTwistBioscience22ndFeb #BerryGene #LatestNewsonBerryGene22ndFeb #LatestPharmaNews22ndFeb #LatestPharmaCollaboration22ndFeb #LatestNewsonGeneticDiseases #China

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

The Future of Indian MedTech Exports: Can India Compete With Global Leaders?September 17, 2026
Robotic-Assisted Procedures Beyond Surgery: Where Is Automation Going Next in Healthcare?September 17, 2026
58 Students from SRM Medical College Selected for Union Government Research Programmes and Grants September 16, 2026
Handpickd Questions the Role of Science in Food with ‘Science-Less’ Newspaper CampaignSeptember 16, 2026
As Women’s Cancer Burden Rises, Integrated Care Emerges as The Next Frontier in Cancer TreatmentSeptember 16, 2026
Odia Superstar Babushaan Mohanty Inaugurates Manoj Das Library at Utkal Gaurav International SchoolSeptember 16, 2026
Yashoda Hospitals, Somajiguda Successfully Treats 10-Month-Old with Complex Heart Condition Through Staged ApproachSeptember 16, 2026
Tracky launches 16D, India's first 16-day continuous glucose monitoring system (CGM)September 16, 2026
Why Local Medical Device Manufacturing Matters for Indian HealthcareSeptember 16, 2026
Next-Generation Surgical Robots Entering the Indian Market: What It Means for Patients and ProvidersSeptember 16, 2026
ShardaCare - Healthcity Marks World Sepsis Day with Training for Over 50 NursesSeptember 15, 2026
From Empowerment to Ownership: Upasana Kamineni Konidela Calls for a BRICS Women’s Economic CorridorSeptember 15, 2026
WORLD HEART DAY 2026: Don't Miss a Beat: The Heart Attacks That Never Had to HappenSeptember 15, 2026
BL Agro Announces Investment of ₹1,500 Crore In Its Biotech-Arm Leads Genetics To Build An Integrated Dairy and Genetics EcosystemSeptember 15, 2026
Can You Have PMOS With Regular Periods? What Women Often Get WrongSeptember 15, 2026
Hospital Data Breaches in India: What Every Patient Needs to Know Right NowSeptember 15, 2026
Cybersecurity of ICUs: Protecting Connected Critical-Care Systems in Indian HospitalsSeptember 15, 2026
Fortis Hospital, Shalimar Bagh Becomes Delhi NCR’s First Multi-speciality Hospital to Launch Rezūm™ Water Vapor Therapy for Enlarged ProstateSeptember 14, 2026
Dr. Reddy's Laboratories Launches Nationwide Educational Initiative to Strengthen India's Obesity Care WorkforceSeptember 14, 2026
IIM Bodh Gaya Hosts Convergence 3.0: The Next Frontier of Healthcare SectorSeptember 14, 2026